A peptide dimer is a complex formed by two peptide chains (peptides or proteins) joined together by chemical bonds (usually covalent or non-covalent). It consists of two identical or different peptide units, which can be of the same amino acid sequence or different amino acid sequences.
Fig. 1. Synthesis of chemically linked peptide dimers (Proceedings of the National Academy of Sciences. 2003, 100(8): 4435-4439).
Covalent Linkage
Non-covalent Linkages
Creative Peptides offers a comprehensive catalog of peptides including standard, modified and cosmetic peptides. These peptides are available in a variety of quantities, from milligrams to kilograms, to meet the varying needs of researchers, pharmaceutical companies and other industries.
A peptide dimer is a molecule where two identical or similar peptide chains (monomers) are linked together through covalent bonds or non-covalent interactions.
They can be formed covalently via disulfide bonds between cysteine residues, through chemical cross-linkers, or by synthesizing branched scaffolds. Non-covalent dimers form through self-assembly driven by interactions like coiled-coil motifs.
Dimerization often increases functional affinity (avidity) for a target by enabling simultaneous binding with two interaction sites, which can significantly enhance binding strength and specificity compared to monomers.
Dimeric peptides are used to study and activate dimeric receptors (e.g., many GPCRs, cytokine receptors) where dimerization is required for signaling, mimicking natural ligand-induced activation.
They can serve as building blocks for self-assembling nanostructures, hydrogels, or as cross-linking agents to control the mechanical properties of biomaterials.
Yes, designed heterodimers can act as potent inhibitors by simultaneously binding two distinct sites on a target protein or by cross-linking two different proteins to disrupt their interaction.
Dimeric presentation of B-cell epitopes can enhance immunogenicity by more effectively cross-linking B-cell receptors, leading to a stronger antibody response.
Reference